This is a multi-centre, multi-drug, platform study in Chinese participants living with obesity/overweight

Trial Identifier:	D8750C00009
Sponsor:	AstraZeneca
Start Date:	May 2025
Primary Completion Date:	August 2026
Study Completion Date:	August 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Jinan, CN, 250001
CN	Nanjing, CN, 210011
CN	Shanghai, CN, 200032

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.